Virus Bulletin, a respected testing authority for security solutions, published its latest ‘VB100 Comparative Review on Windows Server 2008 R2’ report.
ESET submitted the ESET Endpoint Antivirus to the test and once again passed the test with excellent results, receiving its 73rd consecutive VB100 award. In total, ESET has received its 94th VB100 Awards.
“Detection was very strong, with good scores across the board,” say Virus Bulletin’s testing experts as to how ESET Endpoint Antivirus dealt with nearly 900,000 test files.
“ESET Endpoint Antivirus provides companies with comprehensive endpoint protection based on proven ESET technology. Moreover, with next-generation business solution we are focusing on performance and false positives, and it is always good to see this confirmed by an independent tests such as VB100 Comparative Review,” reminds Michal Jankech, Product Manager for Business products.
Besides detection, the comparative review also focused on product stability and performance. According to the VB100 result, stability of ESET Endpoint Antivirus was impeccable, with no problems, even under the heaviest of stress. Further adding, that “resource use was low and our set of activities ran through in good time. Scanning speeds were good to start off with and much faster in repeat runs, and overheads accessing files were very light”.
Learn more about ESET Endpoint protection solutions and about Virus Bulletin’s VB100 Comparative Review on Windows Server 2008 R2.
About ESET
Since 1987, ESET® has been developing award-winning security software that now helps over 100 million users to Enjoy Safer Technology. Its broad security product portfolio covers all popular platforms and provides businesses and consumers around the world with the perfect balance of performance and proactive protection. The company has a global sales network covering 180 countries, and regional offices in Bratislava, San Diego, Singapore and Buenos Aires. For more information visit www.eset.com or follow us on LinkedIn, Facebook and Twitter.